One Stop Shop For Reports One Stop Shop For Reports
  • All Reports
  • All Sectors
    • Chemicals & Materials
      • Advanced Materials
      • Bulk Chemicals
      • Coatings | Paints and Additives
      • Composites
      • Renewable | Speciality chemicals
    • Consumer Goods
      • Baby Products
      • Consumer Electronics
      • Consumer Packaging
      • Cosmetics & Personal Care
      • Homecare & Decor
      • Luxury & premium products
    • Energy and Power
      • Energy Efficiency and Conservation
      • Green | Renewable Energy
      • Non Renewable | Conventional Energy
      • Power Equipment and Devices
    • Life Science
      • Biotechnology
      • Diagnostics
      • Healthcare
      • Healthcare IT
      • Medical Devices & Supplies
      • Pharmaceuticals
    • Food and Beverage
      • Agriculture & Agri Products
      • Beverages
      • Food Ingredients
      • Food Services and Hospitality
      • Nutraceutical | Wellness Food
      • Processed & Frozen Foods
    • Automotive and Transportation
      • Automotive components
      • Automotive Logistics
      • Automotive systems and accessories
    • Information and Communications Technology
      • E Commerce and Outsourcing
      • Entertainment & Media
      • High Tech | Enterprise & Consumer IT
      • Information & Network Security
      • Mobility | Telecom & Wireless
      • Software and Services
    • Semiconductor and Electronics
      • Semiconductor Materials and Components
      • Display Technology
      • Electronics System and Components
      • Emerging technologies
      • Security and Surveillance
      • Sensors and Controls
    • Building and Construction
      • Construction Materials
      • HVAC
      • Residential Construction and Improvement
      • Roads & Highways
    • Manufacturing
      • Manufacturing Services
      • Heavy Manufacturing
      • Packaging
      • Engineering | Equipment and Machinery
  • Who Trust Us
  • [email protected]
  • +1 718 874 1545 (International)
  • +91 78878 22626 (Asia)

More Results

One Stop Shop For Reports One Stop Shop For Reports
  • All Reports
  • All Sectors
    • Chemicals & Materials
      • Advanced Materials
      • Bulk Chemicals
      • Coatings | Paints and Additives
      • Composites
      • Renewable | Speciality chemicals
    • Consumer Goods
      • Baby Products
      • Consumer Electronics
      • Consumer Packaging
      • Cosmetics & Personal Care
      • Homecare & Decor
      • Luxury & premium products
    • Energy and Power
      • Energy Efficiency and Conservation
      • Green | Renewable Energy
      • Non Renewable | Conventional Energy
      • Power Equipment and Devices
    • Life Science
      • Biotechnology
      • Diagnostics
      • Healthcare
      • Healthcare IT
      • Medical Devices & Supplies
      • Pharmaceuticals
    • Food and Beverage
      • Agriculture & Agri Products
      • Beverages
      • Food Ingredients
      • Food Services and Hospitality
      • Nutraceutical | Wellness Food
      • Processed & Frozen Foods
    • Automotive and Transportation
      • Automotive components
      • Automotive Logistics
      • Automotive systems and accessories
    • Information and Communications Technology
      • E Commerce and Outsourcing
      • Entertainment & Media
      • High Tech | Enterprise & Consumer IT
      • Information & Network Security
      • Mobility | Telecom & Wireless
      • Software and Services
    • Semiconductor and Electronics
      • Semiconductor Materials and Components
      • Display Technology
      • Electronics System and Components
      • Emerging technologies
      • Security and Surveillance
      • Sensors and Controls
    • Building and Construction
      • Construction Materials
      • HVAC
      • Residential Construction and Improvement
      • Roads & Highways
    • Manufacturing
      • Manufacturing Services
      • Heavy Manufacturing
      • Packaging
      • Engineering | Equipment and Machinery
  • Who Trust Us
Home ➤ Life Science ➤ Diagnostics ➤ Live Cell Imaging Market
Live Cell Imaging Market
Live Cell Imaging Market
Published date: Oct 2023 • Formats:
Request Sample Schedule a Call
  • Home ➤ Life Science ➤ Diagnostics ➤ Live Cell Imaging Market

Global Live Cell Imaging Market By Type (Consumables, Instruments, Software, and Services), By Application (Cell Biology, Stem Cell and Drug Discovery Developmental Biology, and Others), By Technology (Time-lapse Microscopy, High Content Screening, Fluorescence resonance energy transfer (FRET) and Others), By End User, By Region and Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends, and Forecast 2023-2032

  • Published date: Oct 2023
  • Report ID: 25056
  • Number of Pages: 318
  • Format:
  • Overview
  • Table of Contents
  • Major Market Players
  • Request a Free Sample
  • Quick Navigation

    • Report Overview
    • Key Takeaways
    • Type Analysis
    • Application Analysis
    • Technology Analysis
    • End-User Analysis
    • Key Market Segments
    • Drivers
    • Restraints
    • Opportunity
    • Trends
    • Regional Analysis
    • Key Players Analysis
    • Recent Developments
    • Report Scope

    Report Overview

    In 2022, the Global Live Cell Imaging Market was valued at USD 2.8 Billion and is expected to grow to USD 6.7 billion in 2032. Between 2023 and 2032, this market is estimated to register the highest CAGR of 9.4%.

    The study of living cells using time-lapse microscopy is also known as live-cell imaging. Cell study was also conducted using real-time pictures from several efficient microscopes and screening systems. This advanced technology supports researchers worldwide to detect the processes in real-time and cell structures, offering a better understanding of the cell operations related to the photograph provided by imaging fixed cells.

    The growing concern about cancer is a significant factor in the increasing demand for advanced technology. The government is taking initiatives to invest in cell-based research.

    Live-cell imaging has a wide area of application and can be used to understand cellular structures and active processes. It is operated to investigate cellular integrity, enzyme activity, exocytosis, protein trafficking, molecule localization, endocytosis, and others. The method is used to give path molecules in living animals.

    The pharmaceutical sector increasingly uses live-cell imaging to reveal innovative medicines in development and research. Live-cell imaging is also used in high-content screening. However, the cost of implementing devices is extremely high, hindering this market’s growth. The technique necessitates a highly qualified individual’s study and comprehension of cell activities.

    The lack of experienced specialists also restricts the growth of the Market. However, increasing funding for development programs and training this component has a long-term effect. The pharmaceutical sector widely uses implanting devices. It is expected to increase in demand in the coming future.Global Live Cell Imaging Market growth

    Key Takeaways

    • In 2022, the live cell imaging market was worth US$ 2.8 Billion.
    • The market is projected to reach US$ 6.7 Billion by 2032.
    • The estimated CAGR between 2023 and 2032 is 9.4%.
    • The Instruments segment holds the largest market share in Live Cell Imaging.
    • The Consumables segment is expected to have the highest CAGR in the coming years.
    • Cell Biology is the dominant application in Live Cell Imaging.
    • The Fluorescence Resonance Energy Transfer (FRET) technology segment has the largest market share.
    • Pharmaceutical and Biotechnological Companies are the leading end-users of Live Cell Imaging.
    • The North America region holds the largest market share in Live Cell Imaging.
    • The Asia-Pacific region is expected to experience the fastest growth in the market.
    • Danaher Corporation, Nikon Corporation, and Olympus Corporation are some of the major players in the market.

    Type Analysis

    The Instruments Segment Held the Largest Shares In the Live Cell Imaging Market

    Based on type, the market is segmented into Instruments, Consumables, and Software. Instruments dominated the market, accounting for the largest market share. This is due to the increased use of instruments for analyzing, recording, and gaining insight related to cell operations. The instruments segment covers cell analyzers, image-capturing systems, and standalone systems.

    Technological advances, including the creation of new microscopes, are driving the adoption of instruments. The consumable segment will see the greatest CAGR in the next few years. This is mainly because of the increased demand for consumables in live-cell imaging, resulting in repeated purchases.

    Application Analysis

    Cell Biology Dominates the Product Segment in the Live Cell Imaging Market

    Based on Application, The market is segmented into Cell Biology, Developmental Biology, Stem Cell and Drug Discovery, and Others. Cell biology has emerged as a major segment due to significant growth in research and studies on molecular interaction networks. Live-cell imaging is essential for cell biologists and cell-based researchers. It allows them to understand the elements of cellular structures, as well as the interaction with the tissues.

    This technology provides superior clarity and spatial heterogeneity, which is why it is being adopted in cell biology research. Live cell imaging has become popular due to high-content screening techniques used in drug discovery. There is also a growing demand for faster diagnostic facilities and funding from the government for cell-based research. Live-cell imaging can be used to detect cell-based assays or high-content screening techniques in drug discovery. It helps identify multiple measures of cell biology, including sub-cellular compartments and multicellular structures.Global Live Cell Imaging Market share

    Technology Analysis

    The Fluorescence Resonance Energy Transfer Segment Held the Largest Share In Technology Market Segment

    Based on Technology, the live cell imaging market is segmented into High Content Screening,  Fluorescence resonance energy transfer segment, time-lapse microscopy, and Others. The Fluorescence resonance Energy Transfer segment accounted for the largest percentage due to its many advantages in determining the spatial proximity of the protein levels.

    This technology has become increasingly popular due to the increasing use of genetic peptides. The “Studying SARS-CoV-2 using Fluorescence Microscopy” research revealed that a fluorescent microscope could be used to examine molecular biology and other viruses. This market will grow as more live cell imaging equipment becomes available to study molecular biology.

    End-User Analysis

    Pharmaceutical and Biotechnological Companies Dominate the Market

    Based on End-User, the market is segmented into Biotechnology  & Pharmaceutical Companies, Research & Academic Institutes, and Others. Due to their significant investments in research and development dedicated to the development of new drugs, the Pharmaceutical & Biotechnology Companies dominated this end-user market. Live-cell imaging technology has also been able to benefit from companies’ shifts in interest toward the development of personalized medicine.

    Key Market Segments

    Based on type

    • Consumables
    • Instruments
    • Software
    • Services

    Based on Application

    • Cell Biology
    • Stem Cell and Drug Discovery
    • Developmental Biology
    • Other Applications

    Based on Technology

    • Time-lapse Microscopy
    • Fluorescence resonance energy transfer (FRET)
    • High Content Screening (HCS)
    • Fluorescence Recovery After Photobleaching

    Based on End-User

    • Academic and Research Institutes
    • Pharmaceutical and Biotechnological Companies
    • Contract Research Organisations

    Drivers

    Growing Adaption of High Content Screening Techniques in Drug Discovery

    The live cell imaging market is driven by the adoption of high-content screening methods, government investment for cell-based research, and increasing incidences of cancer. The market’s growth is impeded by a lack of skilled professionals and the high cost of high-content screening systems.

    Market players have growth potential due to the adoption of comfortable screening methods for crucial screening as well as live cell imaging for personalized medicine. These chronic diseases are increasing, which will drive the market for diagnostic services that can provide a reliable and fast diagnosis.

    Restraints

    The High Cost of High Content Screening Systems

    It can be challenging to run live cell imaging experiments efficiently. The success or failure of experiments depends on the condition in which the cells are kept under the microscope. An essential part of experiments is to keep live cells on slides. Temperature plays a crucial role in maintaining cell viability within a culture. Cell viability and cell environment are dependent on several requirements. Therefore, the chances of live cell imaging experiments being unsuccessful are very high.

    High-end content screen instruments are equipped with advanced functionalities & features and are available at a premium price. Because of their limited budgets, Academic Research Laboratories are unable to afford these expensive instruments. Many pharmaceutical companies are concerned about the high price of these instruments because they require high-quality screening systems for their R&D activities.

    Opportunity

    Untapped Potential of Emerging Market

    Due to the growing healthcare industry in emerging countries like Brazil, India, South Africa, and China, the global anatomic pathology market is also increasing. Oncology drug trials use anatomic pathology products to analyze quantitative data, identify structures and pharmacodynamics markers and understand drug mechanisms.

    It separates the subjects based on their tissue response to drugs. Tissue diagnostics make it possible to conduct efficient retrospective and prospective studies. They also reduce the time and cost of the process. These economies have increased their investment in healthcare infrastructure and facilities. The rising market for anatomic pathology products is expected to provide growth opportunities due to the large number of their applications in the healthcare industry.

    Trends

    Increase in Advancement and Newer Imaging Techniques

    In developed countries, the demand for regenerative medicine is increasing. Investments in cell and gene therapy have risen dramatically in recent years. The public and private sectors are leading in funding gene therapy and cell-based research. Many government agencies and private companies have recently started funding biotech start-ups.

    Research institutes to invest in cell, and gene therapy product R&D. The combination of scientific research and technological advancements in imaging and labeling technology allows for live cell imaging. Scientists can use live cell imaging by combining technological advances with biological interests.

    The exciting advancements in probe development have allowed for a wide range of nucleic acids, proteins, glycons, cholesterols, lipids, and metabolites to be labeled. Software that allows for better analysis of label-free images, enabling many recent advances in microscopic technology.

    Regional Analysis

    The North America Region Holds the Largest Market Share and is Expected to Follow the Same Trend over the Forecast Period

    Based on Regional Analysis, the Global Live-Cell Imaging Market can be divided into North America, Europe, Asia Pacific, and the Rest of the World. North America is the largest region in the global Live-Cell Imaging Market. This is due to its rapid adoption of advanced technology and favorable drug development regulations.

    It also has top biotechnology companies and pharmaceutical companies. The region also receives growth funding for various biological research projects. The fastest growth rate is expected in Asia-Pacific, mainly because of significant government investment in research and development and the large number of patients who demand personalized and efficient medicines.

    This growth could be due to the increasing incidence of cancers and other infectious diseases, rising demand for stem cell research studies, rising R&D expenses, increased utility biomarkers for diagnostic purposes, and growing awareness for cell and gene therapies.

    Global Live Cell Imaging Market region

    Key Regions

    • North America
      • The US
      • Canada
      • Mexico
    • Western Europe
      • Germany
      • France
      • The UK
      • Spain
      • Italy
      • Portugal
      • Ireland
      • Austria
      • Switzerland
      • Benelux
      • Nordic
      • Rest of Western Europe
    • Eastern Europe
      • Russia
      • Poland
      • The Czech Republic
      • Greece
      • Rest of Eastern Europe
    • APAC
      • China
      • Japan
      • South Korea
      • India
      • Australia & New Zealand
      • Indonesia
      • Malaysia
      • Philippines
      • Singapore
      • Thailand
      • Vietnam
      • Rest of APAC
    • Latin America
      • Brazil
      • Colombia
      • Chile
      • Argentina
      • Costa Rica
      • Rest of Latin America
    • Middle East & Africa
      • Algeria
      • Egypt
      • Israel
      • Kuwait
      • Nigeria
      • Saudi Arabia
      • South Africa
      • Turkey
      • United Arab Emirates
      • Rest of MEA

    Key Players Analysis

    Developing market players are focused on various strategic policies to improve their own productions in foreign marketplaces. Various live cell imaging market industries are focused on expanding their R&D facilities and present operations.

    However, industries in the live cell imaging market are developing new products, mergers, and portfolio development strategies through investments, and acquisitions. In addition, many key players are now focusing on different marketing strategies, such as increasing awareness about natural components, which helps to boost the target products’ growth.

    With the presence of many local and regional players, the market for Live Cell Imaging devices is fragmented. Market players are subject to intense competition from top market players, particularly those with strong brand recognition and high distribution networks. Companies have gained various expansion strategies, such as partnerships and product launches, to stay on top of the market.

    Below are some of the most prominent Global Live Cell Imaging industry players.

    Market Key Players

    • Danaher Corporation
    • Nikon Corporation
    • Olympus Corporation
    • PerkinElmer, Inc.
    • E. Healthcare
    • Bruker Corporation
    • Thermo Fisher Scientific Inc.
    • Sartorius AG
    • Oxford Instruments
    • BioTech Instruments
    • Bio-Rad Laboratories
    • Etaluma Inc.
    • Other Key Players

    Recent Developments

    • In April 2022: CytoSMART Technologies introduced the Omni FL, a live-cell imaging system incorporating red and green fluorescence channels in its Omni product line.
    • In March 2022: Axion BioSystems is a leader in life sciences devices and focuses on advanced live-cell analysis systems. It has announced the investment of CytoSMART Technologies from the Netherlands. This company is a pioneer in live cell imaging analysis.

    Report Scope

    Report Features Description
    Market Value (2022) USD 2.8 Bn
    Forecast Revenue (2032) USD 6.7 Bn
    CAGR (2023-2032) 9.4%
    Base Year for Estimation 2022
    Historic Period 2016-2022
    Forecast Period 2023-2032
    Report Coverage Revenue Forecast, Market Dynamics, COVID-19 Impact, Competitive Landscape, Recent Developments
    Segments Covered By Type (Consumables, Instruments, Software, and Services); By Application (Cell Biology, Stem Cell, and Drug Discovery,  Developmental Biology, and Others); By Technology (Time-lapse Microscopy, Fluorescence resonance energy transfer (FRET), High Content Screening (HCS) and Fluorescence Recovery After Photobleaching); By End User
    Regional Analysis North America – The US, Canada, & Mexico; Western Europe – Germany, France, The UK, Spain, Italy, Portugal, Ireland, Austria, Switzerland, Benelux, Nordic, & Rest of Western Europe; Eastern Europe – Russia, Poland, The Czech Republic, Greece, & Rest of Eastern Europe; APAC – China, Japan, South Korea, India, Australia & New Zealand, Indonesia, Malaysia, Philippines, Singapore, Thailand, Vietnam, & Rest of APAC; Latin America – Brazil, Colombia, Chile, Argentina, Costa Rica, & Rest of Latin America; the Middle East & Africa – Algeria, Egypt, Israel, Kuwait, Nigeria, Saudi Arabia, South Africa, Turkey, United Arab Emirates, & Rest of MEA
    Competitive Landscape Danaher Corporation, Nikon Corporation, Olympus Corporation, PerkinElmer, Inc., G.E. Healthcare, Bruker Corporation, Thermo Fisher Scientific Inc., Sartorius AG, Oxford Instruments, BioTek Instruments, Bio-Rad Laboratories, Etaluma Inc., Other Key Players
    Customization Scope Customization for segments, region/country-level will be provided. Moreover, additional customization can be done based on the requirements.
    Purchase Options We have three licenses to opt for Single User License, Multi-User License (Up to 5 Users), Corporate Use License (Unlimited User and Printable PDF)

    Frequently Asked Questions (FAQ)

    What is the projected market size of Global Live Cell Imaging Market?

    In 2022, the Global Live Cell Imaging Market was valued at US$ 2.8 Billion and projected to reach US$ 6.7 billion in 2032.

    What is the projected market growth rate of the Live Cell Imaging Market?

    Between 2023 and 2032, this market is estimated to register the highest CAGR of 9.4%.

    Which are the top industry players in the global live cell imaging market?

    Danaher Corporation, Nikon Corporation, Olympus Corporation, PerkinElmer, Inc., E. Healthcare, Bruker Corporation, Thermo Fisher Scientific Inc., Sartorius AG, Oxford Instruments, BioTech Instruments, Bio-Rad Laboratories, Etaluma Inc., Other Key Players.

    Live Cell Imaging Market
    Live Cell Imaging Market
    Published date: Oct 2023
    add_shopping_cartBuy Now get_appDownload Sample
    keyboard_arrow_up
    • Danaher Corporation Company Profile
    • Nikon Corporation Company Profile
    • Olympus Corporation
    • PerkinElmer, Inc.
    • E. Healthcare
    • Bruker Corporation
    • Thermo Fisher Scientific Company Profile
    • Sartorius AG
    • Oxford Instruments
    • BioTech Instruments
    • Bio-Rad Laboratories, Inc. Company Profile
    • Etaluma Inc.
    • Other Key Players
  • settingsSettings

Related Reports

  • Cell Counting Market
  • Cell Dissociation Market
  • Cell and Gene Therapy Market
  • Cell Therapy Market
  • Cell Culture Market
  • Automated Cell Culture Market

Our Clients

  • Our Clients
Inquiry Before Buying

Live Cell Imaging Market
  • 25056
  • Oct 2023
    • ★★★★★
      ★★★★★
    • (79)
add_shopping_cart Buy Now
Trusted by more than 17382 organizations globally
  • Client Logo
  • Client Logo
  • Client Logo
✖
Request a Sample Report
We'll get back to you as quickly as possible

Single User
$6,000
$3,999
USD / per unit
save 24%
Multi User
$8,000
$5,999
USD / per unit
save 28%
Corporate User
$10,000
$6,999
USD / per unit
save 32%
e-Access
Report Library Access
Data Set (Excel)
Print
Company Profile Library Access
Interactive Dashboard
Free Custumization No up to 10 hrs work up to 30 hrs work
Accessibility 1 User 2-5 User Unlimited
Analyst Support up to 20 hrs up to 40 hrs up to 50 hrs
Benefit Up to 20% off on next purchase Up to 25% off on next purchase Up to 30% off on next purchase
Buy Now ($ 3,999) Buy Now ($ 5,999) Buy Now ($ 6,999)
  • location_on420 Lexington Avenue, Suite 300 New York City, NY 10170,
    United States
  • phone+1 718 874 1545 (International)
  • phone+91 78878 22626 (Asia)
  • email[email protected]
  • Facebook Logo
  • Twitter Logo
  • LinkedIn Logo
Find Help
  • Contact Us
  • How to Order
Legal
  • Privacy Policy
  • Refund Policy
  • Frequently Asked Questions
  • Terms and Conditions
Explore
  • About Us
  • All Reports
  • All Sectors
  • Infographics
  • Statistics and Facts
  • Companies
Secured Payment Options
Secured Payment Options

© 2025 Market.Us. All Rights Reserved.